The profile of motor unit number estimation (MUNE) in spinal and bulbar muscular atrophy

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 81, Issue 5, 2010, Pages 567-571

  Suzuki, Keisuke ^a   Katsuno, Masahisa ^a,b   Banno, Haruhiko ^a   Takeuchi, Yu ^a   Kawashima, Motoshi ^a   Suga, Noriaki ^a   Hashizume, Atsushi ^a   Hama, Tetsuo ^a,c   Uchida, Kei ^a,c   Yamashita, Fumitada ^d   Nakamura, Tomohiko ^a,c   Hirayama, Masaaki ^a,c   Tanaka, Fumiaki ^a   Sobue, Gen ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY   (Japan)

^c NAGOYA UNIVERSITY HOSPITAL   (Japan)

^d Nakatsugawa Municipal General Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CELL COUNT; CONTROLLED STUDY; DISEASE DURATION; GRIP STRENGTH; HUMAN; KENNEDY DISEASE; MAJOR CLINICAL STUDY; MOTOR UNIT; PRIORITY JOURNAL; RELIABILITY; AGED; DISEASE COURSE; FEMALE; GENETICS; HAND STRENGTH; HEMISPHERIC DOMINANCE; LONGITUDINAL STUDY; MALE; MIDDLE AGED; MOTONEURON; MUSCLE ATROPHY; MUSCLE STRENGTH; NEUROLOGIC EXAMINATION; ONSET AGE; PATHOLOGY; PHYSIOLOGY; SKELETAL MUSCLE;

BIOLOGICAL MARKER; DNA;

AGE OF ONSET; AGED; BIOLOGICAL MARKERS; CELL COUNT; DISEASE PROGRESSION; DNA; FEMALE; FUNCTIONAL LATERALITY; HAND STRENGTH; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MOTOR NEURONS; MUSCLE FIBERS, SKELETAL; MUSCLE STRENGTH; MUSCULAR DISORDERS, ATROPHIC; NEUROLOGIC EXAMINATION;

EID: 77952564898     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2009.190462     Document Type: Article

References (43)

1. Kennedy WR, Alter M, Sung JH. Progressive proximal spinal and bulbar muscular atrophy of late onset. A sex-linked recessive trait. Neurology 1968;18:671-80.
2. Sobue G, Hashizume Y, Mukai E, et al. X-linked recessive bulbospinal neuronopathy. A clinicopathological study. Brain 1989;112:209-32.
3. Finsterer J. Bulbar and spinal muscular atrophy (Kennedy's disease): a review. Eur J Neurol 2009;16:556-61.
4. La Spada AR, Wilson EM, Lubahn DB, et al. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 1991;352:77-9.
5. Tanaka F, Doyu M, Ito Y, et al. Founder effect in spinal and bulbar muscular atrophy (SBMA). Hum Mol Genet 1996;5:1253-7.
6. Andrew SE, Goldberg YP, Hayden MR. Rethinking genotype and phenotype correlations in polyglutamine expansion disorders. Hum Mol Genet 1997;6:2005-10.
7. Doyu M, Sobue G, Mukai E, et al. Severity of X-linked recessive bulbospinal neuronopathy correlates with size of the tandem CAG repeat in androgen receptor gene. Ann Neurol 1992;32:707-10.
8. Atsuta N, Watanabe H, Ito M, et al. Natural history of spinal and bulbar muscular atrophy (SBMA): a study of 223 Japanese patients. Brain 2006;129:1446-55.
9. Katsuno M, Adachi H, Minamiyama M, et al. Pathogenesis, animal models and therapeutics in spinal and bulbar muscular atrophy (SBMA). Exp Neurol 2006;200:8-18.
10. Harding AE, Thomas PK, Baraitser M, et al. X-linked recessive bulbospinal neuronopathy: a report of ten cases. J Neurol Neurosurg Psychiatry 1982;45:1012-19. (Pubitemid 13234406)
11. Suzuki K, Katsuno M, Banno H, et al. CAG repeat size correlates to electrophysiological motor and sensory phenotypes in SBMA. Brain 2008;131:229-39.
12. Takeuchi Y, Katsuno M, Banno H, et al. Walking capacity evaluated by the 6-minute walk test in spinal and bulbar muscular atrophy. Muscle Nerve 2008;38:964-71.
13. Kachi T, Sobue G, Sobue I. Central motor and sensory conduction in X-linked recessive bulbospinal neuronopathy. J Neurol Neurosurg Psychiatry 1992;55:394-7.
14. Katsuno M, Adachi H, Doyu M, et al. Leuprorelin rescues polyglutamine-dependent phenotypes in a transgenic mouse model of spinal and bulbar muscular atrophy. Nat Med 2003;9:768-73.
15. Banno H, Adachi H, Katsuno M, et al. Mutant androgen receptor accumulation in spinal and bulbar muscular atrophy scrotal skin: a pathogenic marker. Ann Neurol 2006;59:520-6.
16. Banno H, Katsuno M, Suzuki K, et al. Phase 2 trial of leuprorelin in patients with spinal and bulbar muscular atrophy. Ann Neurol 2009;65:140-50.
17. Adachi H, Katsuno M, Minamiyama M, et al. Widespread nuclear and cytoplasmic accumulation of mutant androgen receptor in SBMA patients. Brain 2005;128:659-70.
18. Suzuki K, Katsuno M, Banno H, et al. Pathogenesis-targeting therapeutics for spinal and bulbar muscular atrophy (SBMA). Neuropathology 2009;29:509-16.
19. Felice KJ. A longitudinal study comparing thenar motor unit number estimates to other quantitative tests in patients with amyotrophic lateral sclerosis. Muscle Nerve 1997;20:179-85.
20. Shefner JM. Motor unit number estimation in human neurological diseases and animal models. Clin Neurophysiol 2001;112:955-64.
21. Bromberg MB, Swoboda KJ, Lawson VH. Counting motor units in chronic motor neuropathies. Exp Neurol 2003;184:S53-7.
22. Swoboda KJ, Prior TW, Scott CB, et al. Natural history of denervation in SMA: relation to age, SMN2 copy number, and function. Ann Neurol 2005;57:704-12.
23. Daube JR. Motor unit number estimates - from A to Z. J Neurol Sci 2006;242:23-35.
24. Bromberg MB, Larson WL. Relationships between motor-unit number estimates and isometric strength in distal muscles in ALS/MND. J Neurol Sci 1996;139:S38-42.
25. Lehky TJ, Chen CJ, di Prospero NA, et al. Standard and modified statistical mune evaluations in spinal-bulbar muscular atrophy. Muscle Nerve 2009;40:809-14.
26. Norris FH, Calanchini PR, Fallat RJ, et al. The administration of guanidine in amyotrophic lateral sclerosis. Neurology 1974;24:721-8.
27. The ALS CNTF Treatment Study (ACTS) Phase I-II Study Group. The amyotrophic lateral sclerosis functional rating scale: assessment of activities of daily in patients with ALS. Arch Neurol 1996;53:141-7.
28. Andres PL, Hedlund W, Finison L, et al. Quantitative motor assessment in amyotrophic lateral sclerosis. Neurology 1986;36:937-41. (Pubitemid 16098236)
29. Doherty T, Simmons Z, O'Connell B, et al. Methods for estimating the numbers of motor units in human muscles. J Clin Neurophysiol 1995;12:565-84.
30. Arasaki K, Igarashi O, Ichikawa Y, et al. Reduction in the motor unit number estimate (MUNE) after cerebral infarction. J Neurol Sci 2006;250:27-32.
31. Boe SG, Dalton BH, Harwood B, et al. Inter-rater reliability of motor unit number estimates and quantitative motor unit analysis in the tibialis anterior muscle. Clin Neurophysiol 2009;120:947-52.
32. Brown MC, Holland RL, Hopkins WG. Motor nerve sprouting. Annu Rev Neurosci 1981;4:17-42.
33. Galea V, Fehlings D, Kirsch S, et al. Depletion and sizes of motor units in spinal muscular atrophy. Muscle Nerve 2001;24:1168-72.
34. Albrecht E, Kuntzer T. Number of Edb motor units estimated using an adapted multiple point stimulation method: normal values and longitudinal studies in ALS and peripheral neuropathies. Clin Neurophysiol 2004;115:557-63.
35. Hong YH, Sung JJ, Park KS, et al. Statistical MUNE: a comparison of two methods of setting recording windows in healthy subjects and ALS patients. Clin Neurophysiol 2007;118:2605-11.
36. Boe SG, Stashuk DW, Doherty TJ. Motor unit number estimates and quantitative motor unit analysis in healthy subjects and patients with amyotrophic lateral sclerosis. Muscle Nerve 2007;36:62-70.
37. Aggarwal A, Nicholson G. Detection of preclinical motor neurone loss in SOD1 mutation carriers using motor unit number estimation. J Neurol Neurosurg Psychiatry 2002;73:199-201. (Pubitemid 41652903)
38. Sobue G, Sahashi K, Takahashi A, et al. Degenerating compartment and functioning compartment of motor neurons in ALS: possible process of motor neuron loss. Neurology 1983;33:654-7. (Pubitemid 13080464)
39. Katsuno M, Banno H, Suzuki K, et al. Therapeutic strategies for spinal and bulbar muscular atrophy (SBMA). Drugs Fut 2007;32:907-17.
40. Ravits J, Paul P, Jorg C. Focality of upper and lower motor neuron degeneration at the clinical onset of ALS. Neurology 2007;68:1571-5.
41. Sartucci F, Maritato P, Moscato G, et al. Motor unit number estimation (mune) as a quantitative measure of disease progression and motor unit reorganization in amyotrophic lateral sclerosis. Int J Neurosci 2007;117:1229-36.
42. Biomarkers Definitions Working Group. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 2001;69:89-95.
43. Eisen A, Swash M. Clinical neurophysiology of ALS. Clin Neurophysiol 2001;112:2190-201.